GREENBRAE, Calif.--(BUSINESS WIRE)--MarinHealth interventional cardiologists treated the first patient with a revolutionary new renal denervation (RDN) procedure, now offered for patients with poorly ...

Renal Denervation procedure across its health system, targeting patients with uncontrolled high blood pressure--a therapy shown in clinical trials to reduce major cardiovascular events by 20%, stroke ...

The technique should be used only in patients with truly resistant hypertension, defined as a sustained clinic systolic blood pressure of at least 160 mmHg (150 mmHg in Type 2 diabetes) in patients on ...

TUPELO — High blood pressure, or hypertension, is the top preventable cause of strokes and heart attacks in the United States, according to Dr. Barry Bertolet, an interventional cardiologist at the ...

Cardiologists are welcoming the arrival of a new device-based hypertension treatment called renal denervation and asking Medicare to cover the procedure for a large patient population. Doctors, ...

National coverage analysis is the first-of-its kind for a minimally invasive, interventional treatment for high blood pressure Milestone is supported by large public health need and robust, long-term ...

Deepak L. Bhatt, MD, MPH, MBA, of Mount Sinai Fuster Heart Hospital, spoke at the recent ASPC 2025 Congress on CVD Prevention to illustrate both the benefits and risks associated with renal ...

The minimally invasive procedure targets nerves near the kidneys to help control high blood pressure when medications fail to do so. Dr. Samin Sharma, an interventional cardiologist and director of ...

Renal denervation using radiofrequency energy is a cost-effective and high-value intervention for the treatment of uncontrolled hypertension from the perspective of the US healthcare system, an ...

Please provide your email address to receive an email when new articles are posted on . Data show renal denervation safely lowers BP, but some question the durability of effect. Experts continue to ...

CHICAGO, IL—In the expanded SPYRAL HTN-ON MED trial, renal denervation with the Symplicity Spyral multielectrode catheter (Medtronic) failed to meet its primary endpoint in terms of blood ...

It’s game on in the field of renal denervation, with Medtronic claiming the second FDA green light this month for a procedure to treat drug-resistant high blood pressure—a market its developers expect ...